Induction of Labor by Oral Misoprostol Solution
OMS
A Randomised Control Study of Titrated and Static Oral Misoprostol for Induction of Labor at Term
1 other identifier
interventional
264
1 country
1
Brief Summary
AIM: To evaluate effectiveness and safety of titrated oral misoprostol solution (OMS) in comparison with static-dose oral misoprostol solution for induction of labor at term. Women with singleton live pregnancy at term without any complications who were admitted in labor room for induction of labor were enrolled. Study involves allocation of selected women in two groups randomly and use of either titrated or static oral misoprostol dose regimen to induce labor. Possible benefits included rapid induction of labor with oral drug regimen which is easier to comply as compared to vaginal regimens. Women were at risk of all the complications associated with induction of labor like labor abnormalities, risk of cesarean section, non reassuring fetal status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2018
CompletedFirst Submitted
Initial submission to the registry
May 13, 2021
CompletedFirst Posted
Study publicly available on registry
May 18, 2021
CompletedMay 18, 2021
May 1, 2021
12 months
May 13, 2021
May 13, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Interval between induction and delivery
The time taken from induction of labor to delivery measured as 1\) \<12 hours 2) 12-24 hours 3) 24-48 hours 4) \>48 hours
From first dose of oral misoprostol solution (titrated/static) to childbirth; upto 5 days
Secondary Outcomes (9)
Mean change in modified Bishop's score
From first dose of oral misoprostol solution to childbirth (intrapartum); upto 5 days
Number of misoprostol doses
From first dose of oral misoprostol solution to childbirth (intrapartum); upto 5 days
Time taken to give required doses
From first dose of oral misoprostol solution to childbirth (intrapartum); upto 5 days
Total misoprostol dosage
From first dose of oral misoprostol solution to childbirth (intrapartum); upto 5 days
Mode of delivery
Upto 5 days from first dose of oral misoprostol solution
- +4 more secondary outcomes
Study Arms (2)
Group A (Titrated OMS)
ACTIVE COMPARATORTitrated oral misoprostol solution
Group B (Static OMS)
ACTIVE COMPARATORStatic oral misoprostol solution
Interventions
Based on the WHO labor induction recommendation, and for the purpose of achieving precise oral misoprostol dosage, one misoprostol tablet (200 mcg) was pulverized and dissolved into 200 ml water.90 Thus 1ml of solution had 1mcg of misoprostol. This misoprostol solution could be preserved at room temperature and remained active for 24 hours. Hourly titrated oral misoprostol solution was given to group A as described by Wang X et al, 2016 as described below. 0 hour= 20ml 1. hour= 20ml 2. hour= 30ml 3. hour= 30ml 4. hour= 30ml 5. hour= 40ml 6.5 hour= 50ml 8.5 hour= 60ml 10.5 hour=60ml Group B received 25 mcg (25 ml) oral misoprostol solution every 2 hours for a maximum of 12 doses or until the onset of regular uterine activity.
Eligibility Criteria
You may qualify if:
- Singleton live pregnancy;
- ≥37 weeks gestation;
- Cephalic presentation;
- Reassuring fetal heart rate;
- Modified Bishop'score
You may not qualify if:
- Hypersensitivity to misoprostol;
- Uterine scar due to previous cesarean section or other uterine surgery;
- Grand multipara;
- Multiple gestations;
- High risk pregnanacies • preeeclampsia with severe features • significant maternal cardiac,renal, liver disease
- Any contraindication to induction and vaginal delivery e.g. cephalopelvic disproportion, malpresentation, fetal compromise and ante partum hemorrhage
- Intrauterine fetal demise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Christian Medical College and Hospital
Ludhiana, Punjab, 141008, India
Related Publications (2)
Rouzi AA, Alsahly N, Alamoudi R, Almansouri N, Alsinani N, Alkafy S, Rozzah R, Abduljabbar H. Randomized clinical trial between hourly titrated and 2 hourly static oral misoprostol solution for induction of labor. Am J Obstet Gynecol. 2017 Apr;216(4):405.e1-405.e6. doi: 10.1016/j.ajog.2016.11.1054. Epub 2016 Dec 14.
PMID: 27986461BACKGROUNDAduloju OP, Ipinnimo OM, Aduloju T. Oral misoprostol for induction of labor at term: a randomized controlled trial of hourly titrated and 2 hourly static oral misoprostol solution. J Matern Fetal Neonatal Med. 2021 Feb;34(4):493-499. doi: 10.1080/14767058.2019.1610378. Epub 2019 Apr 29.
PMID: 31006282BACKGROUND
Study Officials
- STUDY CHAIR
SUNITA GOYAL, MBBS, MD
Department of obstetrics and gynecology, Christian Medical College and hospital, Ludhiana
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Women were randomized (1:1) into the treatment groups A) Titrated-dose OMS group B) Static dose OMS group; using computer generated number sequence. Allocation concealment was carried out by using opaque envelopes that were distributed by the obstetrics nurse. Whereas study investigators and attending care teams were aware of the allocated arm, patients were kept blinded to the allocation. Study investigators and outcome assessors could not be blinded as the data collection and analysis included outcome measures like timing of oral misoprostol solution doses.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Resident, Department of obstetrics and gynecology
Study Record Dates
First Submitted
May 13, 2021
First Posted
May 18, 2021
Study Start
December 1, 2017
Primary Completion
November 30, 2018
Study Completion
November 30, 2018
Last Updated
May 18, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be available beginning immediately and ending 36 months following article publication.
- Access Criteria
- Anyone who wishes to access the data for any purpose. Link will be made available at a later date.
IPD that underlie the results reported in the study, after deidentification (text, tables, figures and appendices) will be shared in the excel sheet format.